Solasta Ventures
Home Approach Portfolio
News Team Hatchery Contact
HomeApproachPortfolio
Solasta Ventures
NewsTeamHatcheryContact
ASCO: ‘Any way you slice’ it, Arcellx's CAR-T is matching J&J-Legend’s Carvykti, analyst says
Nia JulianJune 9, 2022
Facebook0 Twitter Pinterest0 0 Likes
Previous

Carbon Biosciences emerges with a new viral vector to shake up the cystic fibrosis gene therapy field

Nia JulianJune 21, 2022
Next

Arcellx raises $124M in Wall Street debut to bankroll study of multiple myeloma CAR-T

Nia JulianFebruary 8, 2022

© 2020 Solasta Ventures. All Rights Reserved.